These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25245783)

  • 1. Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study.
    Sabbadin D; Ciancetta A; Moro S
    J Chem Inf Model; 2014 Oct; 54(10):2846-55. PubMed ID: 25245783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
    Sabbadin D; Ciancetta A; Moro S
    J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water network perturbation in ligand binding: adenosine A(2A) antagonists as a case study.
    Bortolato A; Tehan BG; Bodnarchuk MS; Essex JW; Mason JS
    J Chem Inf Model; 2013 Jul; 53(7):1700-13. PubMed ID: 23725291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
    Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
    J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
    Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
    J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
    Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.
    Keränen H; Gutiérrez-de-Terán H; Åqvist J
    PLoS One; 2014; 9(10):e108492. PubMed ID: 25285959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of adenosine receptors.
    Martinelli A; Ortore G
    Methods Enzymol; 2013; 522():37-59. PubMed ID: 23374179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of the conformational dynamics of the adenosine A2A receptor by means of molecular dynamics simulation].
    Novikov GV; Sivozhelezov VS; Shaĭtan KV
    Biofizika; 2013; 58(4):618-34. PubMed ID: 24455882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing Hydration Patterns in Class-A GPCRs via Biased MD: The A
    Zia SR; Gaspari R; Decherchi S; Rocchia W
    J Chem Theory Comput; 2016 Dec; 12(12):6049-6061. PubMed ID: 27951680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study.
    Ciancetta A; Cuzzolin A; Moro S
    J Chem Inf Model; 2014 Aug; 54(8):2243-54. PubMed ID: 25046649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor.
    Guo D; Pan AC; Dror RO; Mocking T; Liu R; Heitman LH; Shaw DE; IJzerman AP
    Mol Pharmacol; 2016 May; 89(5):485-91. PubMed ID: 26873858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor.
    Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH
    ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.
    Segala E; Guo D; Cheng RK; Bortolato A; Deflorian F; Doré AS; Errey JC; Heitman LH; IJzerman AP; Marshall FH; Cooke RM
    J Med Chem; 2016 Jul; 59(13):6470-9. PubMed ID: 27312113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
    Jaakola VP; Griffith MT; Hanson MA; Cherezov V; Chien EY; Lane JR; Ijzerman AP; Stevens RC
    Science; 2008 Nov; 322(5905):1211-7. PubMed ID: 18832607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraslow Water-Mediated Transmembrane Interactions Regulate the Activation of A2A Adenosine Receptor.
    Lee Y; Kim S; Choi S; Hyeon C
    Biophys J; 2016 Sep; 111(6):1180-1191. PubMed ID: 27653477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substructure-based virtual screening for adenosine A2A receptor ligands.
    van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
    ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.